Half-Yearly Report January – June 2017
April–June in brief · Genovis added five new products to the product portfolio: FabALACTICA™: a unique enzyme for antibody analysis. The enzyme is of particular interest to pharmaceutical companies that develop biological drugs in the growing immunotherapy segment. Three unique enzymes for glycan analysis: OpeRATOR™: a completely unique protease that cleaves proteins at the exact site of a certain type of glycan. OglyZOR™ and SialEXO™: both products have improved performance compared with other similar enzymes on the market and together with OpeRATOR offer a unique and cutting edge